propranolol has been researched along with Essential Tremor in 57 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Essential Tremor: A relatively common disorder characterized by a fairly specific pattern of tremors which are most prominent in the upper extremities and neck, inducing titubations of the head. The tremor is usually mild, but when severe may be disabling. An autosomal dominant pattern of inheritance may occur in some families (i.e., familial tremor). (Mov Disord 1988;13(1):5-10)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The main aim of this study was to evaluate the antitremor effect of 1-Hz (low-frequency) cerebellar rTMS and compare it to the use of propranolol in ET patients." | 9.69 | Cerebellar repetitive transcranial magnetic stimulation versus propranolol for essential tremor. ( Cheng, J; Du, D; Li, H; Lv, Y; Shi, J; Wang, M; Xuan, T; Yang, J; Zhang, J, 2023) |
| "Propranolol is used as the first-line treatment in essential tremor and it has also been proposed as a treatment for tremor in dystonia." | 9.27 | Differential effects of propranolol on head and upper limb tremor in patients with essential tremor and dystonia. ( Berardelli, A; Bologna, M; Cannavacciuolo, A; Cogliati Dezza, F; Fabbrini, G; Ferrazzano, G; Paparella, G, 2018) |
| "Therapeutic efficacy of topiramate in essential tremor (ET) was assessed in comparison with propranolol in two groups which included 24 and 20 patients, respectively, aged from 21 to 83 years (mean age 53 years)." | 9.13 | [Topiramate in the treatment of essential tremor]. ( Latypova, GR; Zalialova, ZA, 2008) |
| "These results suggest that olanzapine might be efficacious for essential tremor." | 9.11 | Olanzapine versus propranolol in essential tremor. ( Başoğlu, M; Irtman, G; Kurt, T; Yetimalar, Y, 2005) |
| "To study the effect of arotinolol and propranolol in a crossover, multiple dose comparative trial of patients with essential tremor." | 9.10 | A multicenter randomized crossover multiple-dose comparison study of arotinolol and propranolol in essential tremor. ( Jeon, BS; Kim, D; Kim, JS; Kim, JW; Lee, KS; Lee, WY, 2003) |
| "To compare the efficacy of clonidine vs propranolol in the control of essential tremor, a double-blind randomized controlled trial with a one year follow-up was designed to obtain 80 % power and 95 % confidence level." | 9.10 | [Clonidine versus propranolol in the treatment of essential tremor. A double-blind trial with a one-year follow-up]. ( Serrano-Dueñas, M, 2003) |
| "To report the novel finding of a significant improvement in essential tremor symptoms with oxcarbazepine in a patient with a suboptimal response to propranolol." | 7.73 | Oxcarbazepine use in essential tremor. ( Landess, JS; Martin, PR; Raj, V, 2006) |
| "We present a 68-year-old patient with essential tremor who was treated with propranolol hydrochloride (80 mg daily) and gabapentin (900 mg daily) after a history of mild success of gabapentin alone in relieving his symptoms." | 7.70 | Dystonia in a patient treated with propranolol and gabapentin. ( Cano, A; Fossas, P; Palomeras, E; Sanz, P, 2000) |
| "The main aim of this study was to evaluate the antitremor effect of 1-Hz (low-frequency) cerebellar rTMS and compare it to the use of propranolol in ET patients." | 5.69 | Cerebellar repetitive transcranial magnetic stimulation versus propranolol for essential tremor. ( Cheng, J; Du, D; Li, H; Lv, Y; Shi, J; Wang, M; Xuan, T; Yang, J; Zhang, J, 2023) |
| "Propranolol is used as the first-line treatment in essential tremor and it has also been proposed as a treatment for tremor in dystonia." | 5.27 | Differential effects of propranolol on head and upper limb tremor in patients with essential tremor and dystonia. ( Berardelli, A; Bologna, M; Cannavacciuolo, A; Cogliati Dezza, F; Fabbrini, G; Ferrazzano, G; Paparella, G, 2018) |
| "Acupuncture combined with oral administration of Propranolol has better therapeutic effect on essential tremor than that of oral administration of Propranolol only." | 5.14 | [Clinical observation on acupuncture combined with medication for treatment of essential tremor]. ( Li, X; Sui, KM, 2010) |
| "Therapeutic efficacy of topiramate in essential tremor (ET) was assessed in comparison with propranolol in two groups which included 24 and 20 patients, respectively, aged from 21 to 83 years (mean age 53 years)." | 5.13 | [Topiramate in the treatment of essential tremor]. ( Latypova, GR; Zalialova, ZA, 2008) |
| "These results suggest that olanzapine might be efficacious for essential tremor." | 5.11 | Olanzapine versus propranolol in essential tremor. ( Başoğlu, M; Irtman, G; Kurt, T; Yetimalar, Y, 2005) |
| "It is a matter of debate whether beta-blockers or primidone have a better influence on essential tremor." | 5.10 | Clinical and electromyographic assessment of essential tremor treatment. ( Milanov, I, 2002) |
| "To study the effect of arotinolol and propranolol in a crossover, multiple dose comparative trial of patients with essential tremor." | 5.10 | A multicenter randomized crossover multiple-dose comparison study of arotinolol and propranolol in essential tremor. ( Jeon, BS; Kim, D; Kim, JS; Kim, JW; Lee, KS; Lee, WY, 2003) |
| "To compare the efficacy of clonidine vs propranolol in the control of essential tremor, a double-blind randomized controlled trial with a one year follow-up was designed to obtain 80 % power and 95 % confidence level." | 5.10 | [Clonidine versus propranolol in the treatment of essential tremor. A double-blind trial with a one-year follow-up]. ( Serrano-Dueñas, M, 2003) |
| "In this systematic review we present information relating to the effectiveness and safety of the following interventions: adding mirtazepine to other antitremor drugs; benzodiazepines; beta-blockers other than propranolol; botulinum A toxin-haemagglutinin complex; calcium channel blockers; carbonic anhydrase inhibitors; clonidine; flunarizine; gabapentin; isoniazid; Phenobarbital; primidone; propranolol; and topiramate." | 4.84 | Essential tremor. ( Ferreira, JJ; Sampaio, C, 2007) |
| "We previously showed that nicotine evoked kinetic tremor by activating the inferior olive, which is implicated in the pathogenesis of essential tremor, via α7 nicotinic acetylcholine receptors." | 3.88 | Pharmacological characterization of nicotine-induced tremor: Responses to anti-tremor and anti-epileptic agents. ( Abe, K; Hashimura, M; Iha, HA; Iwai, C; Kato, M; Kawaji, S; Kawakita, K; Kunisawa, N; Ogawa, M; Ohno, Y; Shimizu, S, 2018) |
| " Exclusion criteria included current β-blocker treatment, spasmodic dysphonia, or other disease that prevented the use of propranolol therapy." | 3.83 | Comparative effectiveness of propranolol and botulinum for the treatment of essential voice tremor. ( Boone, BC; Hapner, ER; Jinnah, HA; Johns, MM; Josephs, JS; Justicz, N, 2016) |
| "3 to 30 mg/kg), a new anticonvulsant drug, in a model of essential tremor in comparison to the reference compounds propranolol and primidone." | 3.74 | Lacosamide, the new anticonvulsant, effectively reduces harmaline-induced tremors in rats. ( Freitag, J; Lekieffre, D; Stöhr, T, 2008) |
| "To report the novel finding of a significant improvement in essential tremor symptoms with oxcarbazepine in a patient with a suboptimal response to propranolol." | 3.73 | Oxcarbazepine use in essential tremor. ( Landess, JS; Martin, PR; Raj, V, 2006) |
| "We present a 68-year-old patient with essential tremor who was treated with propranolol hydrochloride (80 mg daily) and gabapentin (900 mg daily) after a history of mild success of gabapentin alone in relieving his symptoms." | 3.70 | Dystonia in a patient treated with propranolol and gabapentin. ( Cano, A; Fossas, P; Palomeras, E; Sanz, P, 2000) |
| "Tremor is one of the most common movement disorders, though it can arise in the context of several unrelated neurological disorders whose pharmacology and anatomical origins differ greatly." | 2.82 | Medications used to treat tremors. ( Frei, K; Truong, DD, 2022) |
| "Essential tremor is the most common cause of tremor involving upper limbs, head and voice." | 2.66 | Treatment of essential tremor: current status. ( Pandey, S; Sharma, S, 2020) |
| "Essential tremor is one of the most common movement disorders." | 2.61 | Essential Tremor. ( Reich, SG, 2019) |
| "Essential tremor is a common neurologic problem seen widely at all levels of patient care." | 2.47 | Essential tremor: choosing the right management plan for your patient. ( Abboud, H; Ahmed, A; Fernandez, HH, 2011) |
| "Essential tremor is the most common adult movement disorder." | 2.44 | [Therapeutical strategies for essential tremor]. ( Gironell, A, 2007) |
| "Tremor is often a disabling primary condition or secondary to another disorder." | 2.43 | Pharmacological treatment of disabling tremor. ( Charles, PD; Duffis, EI; Schadt, CR, 2005) |
| "Essential tremor is a common movement disorder in adults that interferes with the performance of functional and social activities." | 2.42 | Essential tremor: diagnosis and treatment. ( Chen, JJ; Swope, DM, 2003) |
| "Tremor is a common movement disorder yet many physicians struggle with its terminology as well as with its treatment." | 2.42 | Tremor--easily seen but difficult to describe and treat. ( Grimes, DA, 2003) |
| "Harmaline-induced tremor is an easily provoked model for the development of new therapies for essential tremor (ET)." | 1.91 | Mapping Pharmacologically Evoked Neurovascular Activation and Its Suppression in a Rat Model of Tremor Using Functional Ultrasound: A Feasibility Study. ( Alizad, A; Chang, SY; Fatemi, M; Lee, J; Nayak, R; Sotoudehnia, S, 2023) |
| " nonuse and daily dosage of both primidone and propranolol fluctuated across time for a sizable proportion of ET cases." | 1.72 | Prospective, longitudinal analysis of medication use in a cohort of elderly essential tremor cases. ( Berry, DS; Delgado, N; Hernandez, DI; Louis, ED, 2022) |
| "Essential tremor." | 1.48 | [Essential tremor]. ( Degos, B, 2018) |
| "Essential tremor is the most common movement disorder and is characterised by 4-12 Hz postural and kinetic tremor, but there is no universally accepted diagnostic criterion." | 1.37 | Tongue tremor: a rare initial presentation of essential tremor. ( Brennan, P; Kusanale, A; Wilson, A, 2011) |
| "Essential tremor is the most common movement disorder and has an unknown etiology." | 1.33 | Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice. ( Breese, GR; Criswell, HE; Hamre, K; Homanics, GE; Kralic, JE; Matthews, DB; Morrow, AL; O'Buckley, TK; Osterman, JL; Wilkie, ME, 2005) |
| "These included progressive supranuclear palsy (PSP; n = 2), drug-induced parkinsonism (n = 2), idiopathic Parkinson disease (PD; n = 1), and basal ganglia status cribrosus (n = 1)." | 1.32 | Essential tremor course and disability: A clinicopathologic study of 20 cases. ( Rajput, A; Rajput, AH; Robinson, CA, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.75) | 18.2507 |
| 2000's | 28 (49.12) | 29.6817 |
| 2010's | 18 (31.58) | 24.3611 |
| 2020's | 10 (17.54) | 2.80 |
| Authors | Studies |
|---|---|
| Frei, K | 1 |
| Truong, DD | 1 |
| Shah, C | 1 |
| Jackson, GR | 1 |
| Sarwar, AI | 1 |
| Mandava, P | 1 |
| Jamal, F | 1 |
| Lee, J | 2 |
| Kim, J | 1 |
| Cortez, J | 1 |
| Chang, SY | 2 |
| Delgado, N | 1 |
| Berry, DS | 1 |
| Hernandez, DI | 1 |
| Louis, ED | 3 |
| Vetterick, C | 1 |
| Lyons, KE | 1 |
| Matthews, LG | 1 |
| Pendal, R | 1 |
| Ravina, B | 1 |
| Lv, Y | 1 |
| Wang, M | 1 |
| Yang, J | 1 |
| Shi, J | 1 |
| Xuan, T | 1 |
| Zhang, J | 1 |
| Du, D | 1 |
| Cheng, J | 1 |
| Li, H | 1 |
| Nayak, R | 1 |
| Sotoudehnia, S | 1 |
| Fatemi, M | 1 |
| Alizad, A | 1 |
| Sharma, S | 1 |
| Pandey, S | 1 |
| Zhang, M | 1 |
| Li, W | 1 |
| Hu, L | 1 |
| Chen, L | 1 |
| Yang, L | 1 |
| Zhang, T | 1 |
| Shen, H | 1 |
| Peng, Y | 1 |
| Gao, S | 1 |
| Chen, Z | 1 |
| Wang, T | 1 |
| Zhao, Z | 1 |
| Alonso-Navarro, H | 1 |
| García-Martín, E | 1 |
| Agúndez, JAG | 1 |
| Jiménez-Jiménez, FJ | 1 |
| Deuschl, G | 1 |
| Berg, D | 1 |
| Haubenberger, D | 1 |
| Hallett, M | 1 |
| Kunisawa, N | 1 |
| Shimizu, S | 1 |
| Kato, M | 1 |
| Iha, HA | 1 |
| Iwai, C | 1 |
| Hashimura, M | 1 |
| Ogawa, M | 1 |
| Kawaji, S | 1 |
| Kawakita, K | 1 |
| Abe, K | 1 |
| Ohno, Y | 1 |
| Paparella, G | 1 |
| Ferrazzano, G | 1 |
| Cannavacciuolo, A | 1 |
| Cogliati Dezza, F | 1 |
| Fabbrini, G | 1 |
| Bologna, M | 1 |
| Berardelli, A | 2 |
| Reich, SG | 1 |
| Degos, B | 1 |
| Chung, SJ | 1 |
| Kwon, H | 1 |
| Lee, DK | 1 |
| Hong, JY | 1 |
| Sunwoo, MK | 1 |
| Sohn, YH | 1 |
| Lee, JM | 1 |
| Lee, PH | 1 |
| Huynh, NT | 1 |
| Huot, P | 1 |
| Justicz, N | 1 |
| Hapner, ER | 1 |
| Josephs, JS | 1 |
| Boone, BC | 1 |
| Jinnah, HA | 1 |
| Johns, MM | 1 |
| Buijink, AW | 1 |
| Broersma, M | 1 |
| van der Stouwe, AM | 1 |
| Sharifi, S | 1 |
| Tijssen, MA | 1 |
| Speelman, JD | 1 |
| Maurits, NM | 1 |
| van Rootselaar, AF | 1 |
| Sonkaya, AR | 1 |
| Şenol, MG | 1 |
| Demir, S | 1 |
| Özdağ, FM | 1 |
| Wick, JY | 1 |
| Zanni, GR | 1 |
| Stöhr, T | 1 |
| Lekieffre, D | 1 |
| Freitag, J | 1 |
| Song, IU | 1 |
| Kim, JS | 2 |
| Lee, SB | 1 |
| Ryu, SY | 1 |
| An, JY | 1 |
| Kim, HT | 1 |
| Kim, YI | 1 |
| Lee, KS | 2 |
| Zalialova, ZA | 1 |
| Latypova, GR | 1 |
| Levin, J | 1 |
| Mehrkens, J | 1 |
| Gerbes, A | 1 |
| Bötzel, K | 1 |
| Ferreira, JJ | 1 |
| Sampaio, C | 4 |
| Ferrara, J | 1 |
| Jankovic, J | 1 |
| Sui, KM | 1 |
| Li, X | 1 |
| Diaz, NL | 1 |
| Kusanale, A | 1 |
| Wilson, A | 1 |
| Brennan, P | 1 |
| Abboud, H | 1 |
| Ahmed, A | 1 |
| Fernandez, HH | 1 |
| Yaman, A | 1 |
| Akdeniz, M | 1 |
| Yaman, H | 1 |
| Zappia, M | 1 |
| Albanese, A | 1 |
| Bruno, E | 1 |
| Colosimo, C | 1 |
| Filippini, G | 1 |
| Martinelli, P | 1 |
| Nicoletti, A | 1 |
| Quattrocchi, G | 1 |
| Abbruzzese, G | 1 |
| Allegra, R | 1 |
| Aniello, MS | 1 |
| Elia, AE | 1 |
| Martino, D | 1 |
| Murgia, D | 1 |
| Picillo, M | 1 |
| Squintani, G | 1 |
| Ferreira, J | 3 |
| Grimes, DA | 1 |
| Serrano-Dueñas, M | 1 |
| Kim, JW | 1 |
| Lee, WY | 1 |
| Jeon, BS | 1 |
| Kim, D | 1 |
| Chen, JJ | 1 |
| Swope, DM | 1 |
| Rajput, A | 1 |
| Robinson, CA | 1 |
| Rajput, AH | 1 |
| Troiano, AR | 1 |
| Teive, HA | 1 |
| Fabiani, GB | 1 |
| Zavala, JA | 1 |
| Sá, DS | 1 |
| Germiniani, FM | 1 |
| Camargo, CH | 1 |
| Werneck, LC | 1 |
| Milanov, I | 1 |
| Luggen, AS | 1 |
| Martin, FC | 1 |
| Thu Le, A | 1 |
| Handforth, A | 1 |
| Kralic, JE | 1 |
| Criswell, HE | 1 |
| Osterman, JL | 1 |
| O'Buckley, TK | 1 |
| Wilkie, ME | 1 |
| Matthews, DB | 1 |
| Hamre, K | 1 |
| Breese, GR | 1 |
| Homanics, GE | 1 |
| Morrow, AL | 1 |
| Schadt, CR | 1 |
| Duffis, EI | 1 |
| Charles, PD | 1 |
| Yetimalar, Y | 1 |
| Irtman, G | 1 |
| Kurt, T | 1 |
| Başoğlu, M | 1 |
| Raj, V | 1 |
| Landess, JS | 1 |
| Martin, PR | 1 |
| Gironell, A | 1 |
| Palomeras, E | 1 |
| Sanz, P | 1 |
| Cano, A | 1 |
| Fossas, P | 1 |
| Masuhr, F | 1 |
| Wissel, J | 1 |
| Müller, J | 1 |
| Scholz, U | 1 |
| Poewe, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| the Effects of Repetitive Transcranial Magnetic Stimulation and Mechanisms in Clinical Function of Essential Tremor[NCT06145932] | 40 participants (Anticipated) | Interventional | 2023-11-07 | Recruiting | |||
| Deep braIn Stimulation for Tremor TractographIC Versus Traditional[NCT02491554] | 24 participants (Anticipated) | Interventional | 2015-08-31 | Recruiting | |||
| Environmental Epidemiology of Essential Tremor[NCT04576676] | 1,497 participants (Actual) | Observational | 2020-07-02 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
20 reviews available for propranolol and Essential Tremor
| Article | Year |
|---|---|
Medications used to treat tremors.
Topics: Ataxia; Essential Tremor; Humans; Parkinson Disease; Propranolol; Tremor | 2022 |
Treatment of essential tremor: current status.
Topics: Acetylcholine Release Inhibitors; Adrenergic beta-Antagonists; Botulinum Toxins; Deep Brain Stimulat | 2020 |
Current and Future Neuropharmacological Options for the Treatment of Essential Tremor.
Topics: Adrenergic beta-Antagonists; Animals; Anticonvulsants; Botulinum Toxins, Type A; Electrical Synapses | 2020 |
[Essential tremor: state of the art].
Topics: Age Factors; Deep Brain Stimulation; Diagnosis, Differential; Essential Tremor; Genetic Predispositi | 2018 |
Essential Tremor.
Topics: Ablation Techniques; Adrenergic beta-Antagonists; Anticonvulsants; Contraindications, Drug; Deep Bra | 2018 |
Essential Tremor.
Topics: Adrenergic beta-Antagonists; Aged; Deep Brain Stimulation; Diagnosis, Differential; Essential Tremor | 2019 |
Essential tremor: symptoms and treatment.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anticonvulsants; Essential Tremor; Humans; Mid | 2008 |
Essential tremor.
Topics: Double-Blind Method; Essential Tremor; Humans; Primidone; Propranolol; Tremor | 2007 |
Epidemiology and management of essential tremor in children.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Animals; Child; Clinical Trials as Topic; Diag | 2009 |
Essential tremor: choosing the right management plan for your patient.
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Botulinum Toxins; Deep Brain Stimulation; Diagnosis, D | 2011 |
How best to address these common movement disorders.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Anticonvulsants; Antiparkinson Agents; Es | 2011 |
Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association.
Topics: Animals; Clinical Trials as Topic; Clozapine; Deep Brain Stimulation; Essential Tremor; Humans; Ital | 2013 |
Essential tremor.
Topics: Botulinum Toxins, Type A; Essential Tremor; Humans; Phenobarbital; Propranolol; Randomized Controlle | 2002 |
Tremor--easily seen but difficult to describe and treat.
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Diagnosis, Differential; Essential Tremor; Humans; Pri | 2003 |
Essential tremor: diagnosis and treatment.
Topics: Acetates; Amines; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Essential Tremor; Gabapentin | 2003 |
Essential tremor.
Topics: Adrenergic beta-Antagonists; Barbiturates; Essential Tremor; Humans; Propranolol | 2003 |
Pharmacological treatment of disabling tremor.
Topics: Botulinum Toxins, Type A; Dystonia; Essential Tremor; Humans; Parkinson Disease; Primidone; Proprano | 2005 |
Essential tremor.
Topics: Adrenergic beta-Antagonists; Barbiturates; Benzodiazepines; Botulinum Toxins, Type A; Essential Trem | 2005 |
[Therapeutical strategies for essential tremor].
Topics: Adult; Aged; Alprazolam; Amines; Antipsychotic Agents; Botulinum Toxins, Type A; Calcium Channel Blo | 2007 |
Clinical practice. Essential tremor.
Topics: Adrenergic beta-Antagonists; Aged; Anticonvulsants; Benzodiazepines; Diagnosis, Differential; Electr | 2001 |
10 trials available for propranolol and Essential Tremor
| Article | Year |
|---|---|
Cerebellar repetitive transcranial magnetic stimulation versus propranolol for essential tremor.
Topics: Cerebellum; Essential Tremor; Humans; Propranolol; Transcranial Magnetic Stimulation; Treatment Outc | 2023 |
Differential effects of propranolol on head and upper limb tremor in patients with essential tremor and dystonia.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Dystonia; Essential Tremor; Female; Humans; Ma | 2018 |
Effects of zonisamide on isolated head tremor.
Topics: Adrenergic beta-Antagonists; Aged; Anticonvulsants; Consciousness Disorders; Dose-Response Relations | 2008 |
[Topiramate in the treatment of essential tremor].
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Essential Tremor; Female; Fructose; Humans; Male; M | 2008 |
[Clinical observation on acupuncture combined with medication for treatment of essential tremor].
Topics: Acupuncture Points; Acupuncture Therapy; Aged; Combined Modality Therapy; Essential Tremor; Female; | 2010 |
[Clonidine versus propranolol in the treatment of essential tremor. A double-blind trial with a one-year follow-up].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Clonidine; Double-Blind Method; Essent | 2003 |
A multicenter randomized crossover multiple-dose comparison study of arotinolol and propranolol in essential tremor.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Essential Tremor; F | 2003 |
[Clinical response to long action propranolol in 40 patients diagnosed with essential tremor with no previous treatment: an open, non-controlled study].
Topics: Adrenergic beta-Antagonists; Adult; Essential Tremor; Female; Humans; Male; Propranolol; Severity of | 2004 |
Clinical and electromyographic assessment of essential tremor treatment.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Anticonvulsants; Cross-Over Studies; El | 2002 |
Olanzapine versus propranolol in essential tremor.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Benzodiazepines; Cross-Over Studies; Do | 2005 |
27 other studies available for propranolol and Essential Tremor
| Article | Year |
|---|---|
Treatment Patterns in Essential Tremor: A Retrospective Analysis.
Topics: Essential Tremor; Humans; Primidone; Propranolol; Retrospective Studies; Topiramate | 2022 |
Thalamo-cortical network is associated with harmaline-induced tremor in rodent model.
Topics: Animals; Deep Brain Stimulation; Essential Tremor; Harmaline; Motor Cortex; Propranolol; Rats; Roden | 2022 |
Prospective, longitudinal analysis of medication use in a cohort of elderly essential tremor cases.
Topics: Aged; Aged, 80 and over; Essential Tremor; Humans; Longitudinal Studies; Primidone; Propranolol; Tre | 2022 |
The Hidden Burden of Disease and Treatment Experiences of Patients with Essential Tremor: A Retrospective Claims Data Analysis.
Topics: Cost of Illness; Data Analysis; Essential Tremor; Humans; Propranolol; Retrospective Studies | 2022 |
Mapping Pharmacologically Evoked Neurovascular Activation and Its Suppression in a Rat Model of Tremor Using Functional Ultrasound: A Feasibility Study.
Topics: Animals; Essential Tremor; Feasibility Studies; Harmaline; Propranolol; Rats; Tremor | 2023 |
Oral propranolol for treatment of the subgroups of essential tremor: a systematic review and meta-analysis protocol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Essential Tremor; Gait; Humans; Meta-Analysis as | 2020 |
Pharmacological characterization of nicotine-induced tremor: Responses to anti-tremor and anti-epileptic agents.
Topics: Animals; Anticonvulsants; Antiparkinson Agents; Benzeneacetamides; Calcium Channel Blockers; Carbama | 2018 |
[Essential tremor].
Topics: Essential Tremor; Humans; Propranolol; Radiosurgery; Thalamus; Treatment Outcome; Ultrasonography | 2018 |
Neuroanatomical heterogeneity of essential tremor according to propranolol response.
Topics: Adrenergic beta-Antagonists; Aged; Anisotropy; Cerebral Cortex; Diffusion Tensor Imaging; Essential | 2013 |
Propranolol-induced Somnambulism: A Case-report in a Patient with Essential Tremor.
Topics: Adrenergic beta-Antagonists; Adult; Essential Tremor; Female; Humans; Propranolol; Somnambulism | 2014 |
Comparative effectiveness of propranolol and botulinum for the treatment of essential voice tremor.
Topics: Adrenergic beta-Antagonists; Aged; Botulinum Toxins, Type A; Comparative Effectiveness Research; Dys | 2016 |
Cerebellar Atrophy in Cortical Myoclonic Tremor and Not in Hereditary Essential Tremor-a Voxel-Based Morphometry Study.
Topics: Adult; Age of Onset; Atrophy; Cerebellum; Epilepsies, Myoclonic; Essential Tremor; Female; Gray Matt | 2016 |
The investigation into the cutaneous silent period in patients with essential tremor pre-treatment and post-treatment.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Electromyography; Essential Tremor; Female; Humans; | 2016 |
Lacosamide, the new anticonvulsant, effectively reduces harmaline-induced tremors in rats.
Topics: Acetamides; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Esse | 2008 |
Essential tremor leading to toxic liver damage successfully treated with deep brain stimulation.
Topics: Adrenergic beta-Antagonists; Aged; Alcoholism; Anticonvulsants; Central Nervous System Depressants; | 2009 |
Survey of medication usage patterns among essential tremor patients: movement disorder specialists vs. general neurologists.
Topics: Adult; Aged; Anticonvulsants; Drug Utilization; Essential Tremor; Female; Health Surveys; Humans; Ma | 2010 |
Tongue tremor: a rare initial presentation of essential tremor.
Topics: Adrenergic beta-Antagonists; Essential Tremor; Female; Humans; Propranolol; Tongue Diseases | 2011 |
Controlling essential tremor.
Topics: Diagnosis, Differential; Essential Tremor; Health Status; Humans; Middle Aged; Neurologic Examinatio | 2012 |
Essential tremor course and disability: A clinicopathologic study of 20 cases.
Topics: Adrenergic beta-Antagonists; Age of Onset; Aged; Antiparkinson Agents; Disability Evaluation; Diseas | 2004 |
Essential tremor in the older adult: coping with primary symptoms.
Topics: Acetates; Adaptation, Psychological; Adrenergic beta-Antagonists; Aged; Alprazolam; Amines; Anticonv | 2004 |
Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications.
Topics: Animals; Central Nervous System Depressants; Central Nervous System Stimulants; Essential Tremor; Et | 2005 |
Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice.
Topics: Adrenergic beta-Antagonists; Animals; Anticonvulsants; Disease Models, Animal; Dizocilpine Maleate; | 2005 |
Oxcarbazepine use in essential tremor.
Topics: Adult; Carbamazepine; Essential Tremor; Female; Humans; Oxcarbazepine; Propranolol | 2006 |
My husband has been diagnosed with essential tremor, or ET. What is this, and how is it different from Parkinson's disease? What is the treatment?
Topics: Essential Tremor; Humans; Parkinson Disease; Propranolol | 2008 |
Setting a steady course for benign essential tremor.
Topics: Adrenergic beta-Antagonists; Aged; Anticonvulsants; Electric Stimulation Therapy; Essential Tremor; | 1999 |
Dystonia in a patient treated with propranolol and gabapentin.
Topics: Acetates; Adrenergic beta-Antagonists; Aged; Amines; Antiparkinson Agents; Cyclohexanecarboxylic Aci | 2000 |
Quantification of sensory trick impact on tremor amplitude and frequency in 60 patients with head tremor.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Anticonvulsants; Central Nervous System | 2000 |